Redhawk Wealth Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Redhawk Wealth Advisors, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $17.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$17.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 6,258 | $5.8M |
| HALOHALOZYME THERAPEUTICS, INC. | 32,861 | $2.1M |
| MRKMerck & Co., Inc. | 14,176 | $1.7M |
| CAHCardinal Health Inc. | 7,675 | $1.6M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 28,226 | $1.6M |
| PFEPFIZER INC | 49,947 | $1.4M |
| JNJJOHNSON & JOHNSON | 3,134 | $766K |
| ABBVAbbVie Inc. | 3,161 | $688K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,164 | $520K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,908 | $516K |
| MCKMcKesson Corporation | 339 | $293K |
| BMYBRISTOL MYERS SQUIBB CO | 4,101 | $249K |
| ABTABBOTT LABORATORIES | 2,221 | $228K |
| TNYATenaya Therapeutics, Inc. | 65,350 | $45K |
| ATYRaTYR PHARMA INC | 49,150 | $38K |
| SGMOSANGAMO THERAPEUTICS, INC | 119,400 | $29K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.